NCT00629057View on ClinicalTrials.gov

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

September 30, 2011

Conditions
Androgen-insensitive Prostate Cancer
Interventions
BIOLOGICAL

MVA-BN-PRO

1x10e8 TCID50 q 4 wks x 6

BIOLOGICAL

MVA-BN-PRO

2 x 10e8 TCID50 q 4 wks x 6

BIOLOGICAL

MVA-BN-PRO

4 x 10e8 TCID50 q 4 wks x 6

Trial Locations (7)

20307

Walter Reed Army Medical Center, Washington D.C.

28173

Presbyterian Hospital Center for Cancer Research, Charlotte

35209

Urology Centers of Alabama, Homewood

75231

Urology Clinics of North Texas, PA, Dallas

78503

Urology Associates of South Texas, McAllen

08648

Lawrenceville Urology, Lawrenceville

Unknown

Urology Associates, Nashville

Sponsors

Lead Sponsor

Bavarian Nordic
All Listed Sponsors
lead

Bavarian Nordic

INDUSTRY

NCT00629057 - A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer | Biotech Hunter | Biotech Hunter